Publication Name	World Journal of Stem Cells
Manuscript ID	94408
Country	India

Received	2024-03-18 09:10
Peer-Review Started	2024-03-18 09:11
To Make the First Decision
Return for Revision	2024-05-16 00:39
Revised	2024-05-28 13:03
Second Decision	2024-06-06 02:58
Accepted by Journal Editor-in-Chief	2024-06-07 19:40
Accepted by Executive Editor-in-Chief	2024-06-24 08:30
Articles in Press	2024-06-24 08:30
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-06-30 21:07
Typeset the Manuscript	2024-07-09 07:22
Publish the Manuscript Online	2024-07-25 07:15

ISSN	1948-0210 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Review
Article Title	Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury
Manuscript Source	Invited Manuscript
All Author List	Prashasti Sharma and Dharmendra Kumar Maurya
Funding Agency and Grant Number
Corresponding Author	Dharmendra Kumar Maurya, BSc, MSc, PhD, N/A, N/A, Radiation Biology & Health Sciences Division, Bhabha Atomic Research Centre, 3-82-S, A-block, Modular Laboratory, Mumbai 400085, Maharashtra, India. dkmaurya@barc.gov.in
Key Words	Stem cells; Wharton’s jelly mesenchymal stem cells; Radiotherapy; Xerostomia; Lung fibrosis
Core Tip	Stem cells, particularly Wharton’s Jelly mesenchymal stem cells (WJ-MSCs), are pivotal in cell-based therapy due to their robust tissue repair abilities. While radiotherapy is a common cancer treatment, it often causes collateral damage to healthy tissues, reducing its efficacy. WJ-MSCs, resembling embryonic stem cells, exhibit superior differentiation and safety, making them ideal for both autologous and allogeneic transplants. This review emphasizes WJ-MSCs’ regenerative potential and clinical utility in alleviating radiation-induced injuries resulting from radiotherapy across various cancer types.
Publish Date	2024-07-25 07:15
Citation	<p>Sharma P, Maurya DK. Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury. <i>World J Stem Cells</i> 2024; 16(7): 742-759</p>
URL	https://www.wjgnet.com/1948-0210/full/v16/i7/742.htm
DOI	https://dx.doi.org/10.4252/wjsc.v16.i7.742

Full Article (PDF)	WJSC-16-742-with-cover.pdf
Manuscript File	94408-Review-FilipodiaCL.docx
Answering Reviewers	94408-answering-reviewers.pdf
Audio Core Tip	94408-audio.mp3
Conflict-of-Interest Disclosure Form	94408-conflict-of-interest-statement.pdf
Copyright License Agreement	94408-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	94408-non-native-speakers.pdf
Peer-review Report	94408-peer-reviews.pdf
Journal Editor-in-Chief Review Report	94408-journal-editor-in-chief.pdf
Scientific Misconduct Check	94408-scientific-misconduct-check.png
Scientific Editor Work List	94408-scientific-editor-work-list.pdf
CrossCheck Report	94408-crosscheck-report.pdf